AI + 健康未来式：看鱼跃医疗如何革新基础监测体验

Group 1: Company Overview - Yuyue Medical held a product launch event themed "AI + Health Future" to enhance home health management through AI technology [1] - In the 2024 financial report, the company reported R&D investment of 547 million yuan, an increase of 8.39% year-on-year, accounting for 7.23% of revenue, with a five-year compound annual growth rate of 18.39% [1] - Yuyue Medical has drafted four national standards and one local standard, completed two major national key R&D projects, and received 200 new patent authorizations in the year [1] Group 2: Product Innovations - Yuyue Medical launched five new products in the diagnostic monitoring sector, including the S series atrial fibrillation blood pressure monitor and a multi-functional home vital signs monitor [1][2] - The new home vital signs monitor integrates six measurement functions, addressing accessory storage and data management issues for chronic disease patients [2] Group 3: AI Integration - The company is focusing on integrating AI technology into health management, with the S series blood pressure monitor featuring a dual measurement design for precise screening of blood pressure and atrial fibrillation [3] - Yuyue Medical introduced the Yuyue AI Health Manager, which combines its product matrix with an intelligent health management ecosystem, allowing users to easily collect, analyze, and manage health data [3] Group 4: Future Vision - The chairman of Yuyue Medical emphasized that AI wearable medical devices will transform health management and optimize medical services, aligning with the company's mission to alleviate patient suffering and enhance physician skills [4] - The company aims to explore a fully integrated intelligent system for monitoring, warning, and intervention, enhancing health benefits for families through technological advancements [4]